Graham S Scott
Iowa State University, Ames, USA.
J Med Humanit. 2011 Sep;32(3):167-86. doi: 10.1007/s10912-011-9137-5.
Recent scholarship in medical humanities has expressed strong concern over the ability of pharmaceuticals companies to medicalize discomfort and subsequently invent diseases. In this article, I explore the clinical debates over the ontology of the sinus headache as a possible counter-case. Extending Foucault's concept of principles or rarefaction, this paper documents the efforts of clinicians to resist the pharmaceutically-provided understanding of the sinus headache. In so doing, it offers institutions of rarefaction and rarefactive assemblages as useful heuristics for the exploration of disease legitimization discourse.
近期医学人文学科的学术研究对制药公司将不适医学化并随后发明疾病的能力表达了强烈关注。在本文中，我探讨了关于鼻窦性头痛本体论的临床辩论，将其作为一个可能的反例。本文扩展了福柯的原则或稀薄化概念，记录了临床医生抵制制药公司所提供的对鼻窦性头痛的理解的努力。在此过程中，它提供了稀薄化机构和稀薄化组合，作为探索疾病合法化话语的有用启发法。
